Back to 
HSBC HOLDINGS PLC
HSBC HOLDINGS PLC
RADX2 quarters
Position history for HSBC HOLDINGS PLC's holdings in Radiopharm Theranostics
HSBC HOLDINGS PLC holds 61,372 shares of RADX (Radiopharm Theranostics), worth $264,513 as of 2026-Q1. The position was decreased (-68.0% shares). RADX represents 0.0% of HSBC HOLDINGS PLC's portfolio.
Current Value
$264,513
Current Shares
61,372
Total Value Change
-$742,471
Total Shares Change
-130,252
Quarter-by-Quarter History
Other major holders of RADX: UBS Group AG, PNC FINANCIAL SERVICES GROUP, INC., Virtu Financial LLC